CLOSED STUDIES / Endometrial Cancer



Phase IV-II trial of Temozolomide in a continuous oral administration schedule in the treatment of Gynaecological Sarcomas.

GEICO Coordinator

Dr. Andrés Poveda

Patients Recruited

14 patients

Inclusion Closing Date

September 2005


García del Muro X, Poveda A, Buesa JM, Martínez-Trufero J, González de Sande LM, Calvo E, Escudero P, López-Pousa A, Fabregat X, Casado A Phase II Trial of Temozolomide as First-line Treatment for Patients with Advanced Gynecological Sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) Study. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 9570.